Epoch 4: Biotech Contrarian Investing

Required Psychology and Contrarian Catalysts

Welcome to the 64 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 1,601 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:

Hello Avatar! Welcome back for another week of biotech analysis. Last week we took a close look at the psychological profiles of winning founders and teams.  This week we are staying on the psychology topic and talking about contrarian investing.  Going against the grain is the most effective way to identify the outlier winners.  It also takes a unique mindset to embrace this strategy, particularly for high stakes.  Today we will not only get into the academic concepts of this approach, but also give you a handful of specific contrarian biotech and pharma plays to explore should you choose.

If you're not subbed yet click the link below.  Every Thursday we are out with our FREE public/private biotech market update. Sundays are the days we focus on forward looking strategy.  Monday’s are for public equity research.  Tomorrow we will focus on 4D Therapeutics ($FDMT) with upcoming data from the C102 Ph1/2 Fabry disease program in early February.  The options market is projecting a 20% move on the news, so it should be interesting!

Please help spread the work by subscribing and hitting the share button if you are enjoying our bi-weekly newsletters!

Enough shilling for the day, lots to cover this week, let's get started!

CONTRARIAN INVESTING STRATEGIES